News related to Zomig (Zolmitriptan) and/or conditions it is approved for
New Scientific Review Shows That Zolmitriptan ('Zomig(TM)') Nasal Spray Provided Efficacious Relief From Cluster Headache
Source: Headache / Migraine News From Medical News Today [2008.09.08]
Results from a new pooled data analysis presented at the European Headache and Migraine Trust International Congress (EHMTIC) 2008 today show that zolmitriptan ('Zomig') nasal spray provided fast and efficacious relief in the treatment of episodic and chronic cluster headache.
Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
Source: Headache / Migraine News From Medical News Today [2008.11.25]
Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, a widely-used migraine treatment, but with fewer associated adverse effects. These are the conclusions of an Article published Online first and in and upcoming edition of The Lancet, written by Dr Tony Ho, Merck Research Laboratories, North Wales, Philadelphia, USA, and colleagues.
New Migraine Drug Shows Promise
Source: MedicineNet Clinical Trials Specialty [2008.11.25]
Title: New Migraine Drug Shows Promise
Category: Health News
Created: 11/25/2008 2:00:00 AM
Last Editorial Review: 11/25/2008
Patent Foramen Ovale Closure Extremely Promising For Stroke Prevention And Treatment Of Migraine
Source: Headache / Migraine News From Medical News Today [2008.11.24]
There continues to be a disagreement between the neurological and vascular communities as to when to close the PFO (Patent Foramen Ovale) - the hole in the heart between the right and left atria): the former state that it should be done only after the occurrence of the second stroke, with anticoagulation medicines administered after the first stroke, and this is currently the prevailing practice.
Investigational Telcagepant Effective in Migraine
Source: MedPage Today Neurology [2008.11.24]
NORTH WALES, Pa. (MedPage Today) -- The investigational migraine medication telcagepant is as effective as a standard therapy and has fewer adverse effects, researchers here said.
Overuse Of Narcotics And Barbiturates May Make Migraine Worse
Source: Alcohol / Addiction / Illegal Drugs News From Medical News Today [2008.11.20]
A team of researchers led by investigators at the Albert Einstein College of Medicine of Yeshiva University has determined that certain commonly-prescribed medications may have the unintended consequence of increasing the frequency of migraine attacks. This important finding could alter the way doctors prescribe migraine medicines.
500-Patient Study Measuring Cognitive Processing Efficiency During Migraine Attacks
Source: Headache / Migraine News From Medical News Today [2008.11.17]
PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 360 clinical trials worldwide, is providing its innovative LogPad(R) System to help headache experts at Clinvest Clinical Research measure cognitive deficits during migraine attacks in a sponsored clinical trial. This is the first time cognitive processing time has been tested in a major migraine research study.
Migraine Might Lower Breast Cancer Risk
Source: MedicineNet Headache Specialty [2008.11.07]
Title: Migraine Might Lower Breast Cancer Risk
Category: Health News
Created: 11/7/2008 2:00:00 AM
Last Editorial Review: 11/7/2008
Breakthrough's Comment On Research Suggesting Women Who Have Migraines Have A Reduced Risk Of Breast Cancer
Source: Headache / Migraine News From Medical News Today [2008.11.06]
Research to be published in Cancer Epidemiology, Biomarkers and Prevention suggests that women who suffer from migraines may have a reduced risk of developing certain types of breast cancer. Dr Sarah Cant, Policy Manager at Breakthrough Breast Cancer, says: "This small study is the first to suggest that women who suffer migraines may have a reduced risk of developing certain types of breast cancer, so needs to be backed up by further research.
Women Who Have Migraines Have Lower Breast Cancer Risk
Source: Headache / Migraine News From Medical News Today [2008.11.06]
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
Minster Pharmaceuticals Plc Announces Positive Results From Phase II Trial Of Migraine With Aura
Source: Headache / Migraine News From Medical News Today [2008.10.25]
Minster Pharmaceuticals plc (AIM: MPM), the drug development company specializing in neurological and psychiatric disorders, is pleased to announce positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura. The median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo.
Targeting Neuropeptides Could Be Future For Migraine Treatment
Source: Headache / Migraine News From Medical News Today [2008.10.20]
Targeting a system which utilises peptides in the brain during a migraine could be the future of treatment for this debilitating condition. The future and recent developments in the field of migraine are discussed in a Comment in this week's edition of The Lancet, written by Dr Stephen D Silberstein, Thomas Jefferson University, Philadelphia, PA, USA.
Janet Jackson's Vestibular Migraines: FAQ
Source: MedicineNet Fainting Specialty [2008.10.16]
Title: Janet Jackson's Vestibular Migraines: FAQ
Category: Health News
Created: 10/16/2008
Last Editorial Review: 10/16/2008
Chronic Migraines Caused By A Hole In The Heart? "Highly Likely," New Research Says
Source: Headache / Migraine News From Medical News Today [2008.10.15]
New research unveiled at TCT 2008 by Dr. Stephen Silberstein (a leading neurologist) suggests that 66 percent of chronic migraine sufferers have abnormal blood flow caused by a hole in their heart or a right-to-left shunt that bypasses the filtration process of the lungs. Most of these defects are known as a PFO, a heart condition prior research shows is found in 25 percent of the population.
Vestibular Migraine and Janet Jackson
Source: MedicineNet Migraine Headache Specialty [2008.10.15]
Title: Vestibular Migraine and Janet Jackson
Category: Doctor's Views
Created: 10/15/2008
Last Editorial Review: 10/15/2008
Migraine Action Plan Could Help Millions Of Sufferers Find A Positive Way Out Of Migraine
Source: Headache / Migraine News From Medical News Today [2008.10.14]
Migraines can be a debilitating condition and affect around 15% of the UK population, over 70% of whom are women. Recent research undertaken by Imigran Recovery reveals that over 81% of migraine sufferers cannot always control their migraine attacks while 71% say migraines leave them unable to function. For the 81% who are unable to control their migraines, a new interactive tool www.migraineactionplan.co.uk has been developed.
Migraines More Frequent, Intense in Overweight Kids
Source: MedicineNet Migraine Headache Specialty [2008.09.29]
Title: Migraines More Frequent, Intense in Overweight Kids
Category: Health News
Created: 9/27/2008 2:00:00 AM
Last Editorial Review: 9/29/2008
Migraine Research Foundation Announces Winners Of Grants To Spur Innovation In Migraine Research
Source: Headache / Migraine News From Medical News Today [2008.09.22]
The Migraine Research Foundation (MRF), the largest nonprofit funder of migraine research in the United States, today announced the winners of its second round of grants intended to spur innovation in migraine research. The grants totaled $200,000. The grantees were screened by MRF's medical advisory board, which is composed of leading scientists and clinicians from across the country.
Migraine Linked To Blood Clots In Veins
Source: Headache / Migraine News From Medical News Today [2008.09.17]
People with migraines may also be more likely to develop blood clots in their veins, according to a study published in the September 16, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. In the condition, called venous thrombosis or thromboembolism, blood clots form in a vein, which can limit blood flow and cause swelling and pain. Those clots can then dislodge from the vein and travel to the heart and the lungs, which can be fatal.
Migraines Linked to Vein Blood Clots
Source: MedicineNet Deep Vein Thrombosis Specialty [2008.09.16]
Title: Migraines Linked to Vein Blood Clots
Category: Health News
Created: 9/16/2008
Last Editorial Review: 9/16/2008
Oral CGRP Receptor Antagonist Showed Statistically Significant Improvement In Migraine Relief Versus Placebo
Source: Headache / Migraine News From Medical News Today [2008.09.08]
Merck Sharp & Dohme Limited announced that in a Phase III clinical trial telcagepant (formerly known as MK-0974) - an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist - significantly relieved moderate-to-severe migraine attacks, including migraine pain and migraine-associated symptoms, compared to placebo. In addition, the overall rates of adverse events in this trial were similar for telcagepant and placebo.
Migraine With Aura May Be Linked To Increased Risk Of Stroke And Heart Attacks And Must Be Taken Seriously By GPs
Source: Headache / Migraine News From Medical News Today [2008.09.08]
Doctors need to pay special attention to people with migraine with aura as they could be at increased risk of stroke or heart attack, a London conference heard today. Professor Tobias Kurth, a leading neuroepidemiologist from Harvard Medical School, USA, has found the links between migraine with aura and cardiovascular events are now so strong that GPs need to take them seriously.
Phase II Results Of COL-144 Presented At European Headache And Migraine Trust International Congress 2008
Source: Headache / Migraine News From Medical News Today [2008.09.08]
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches. COL-144 is a first-in-class Neurally Acting Anti- Migraine Agent (NAAMA), which unlike triptans, exhibits anti-migraine activity without causing vasoconstriction.
Army Personnel Show Increased Risk For Migraine - Condition Underdiagnosed, Mistreated
Source: Headache / Migraine News From Medical News Today [2008.08.29]
Two new studies show that migraine headaches are very common among U.S. military personnel, yet the condition is frequently underdiagnosed. The studies, appearing in Headache, the peer-reviewed journal of the American Headache Society, examine the incidence among soldiers within 10 days of returning from a 1-year combat tour in Iraq , as well as U.S. Army officer trainees. The U.S.
Health Tip: Managing Your Child's Migraines
Source: MedicineNet Migraine Headache Specialty [2008.08.08]
Title: Health Tip: Managing Your Child's Migraines
Category: Health News
Created: 8/8/2008 2:00:00 AM
Last Editorial Review: 8/8/2008
Women's Migraines Multiply Heart Risk
Source: MedicineNet Migraine Headache Specialty [2008.07.31]
Title: Women's Migraines Multiply Heart Risk
Category: Health News
Created: 7/31/2008
Last Editorial Review: 7/31/2008
Migraine Medications May Cause 'Serotonin Syndrome'
Source: MedicineNet Palpitations Specialty [2008.05.15]
Title: Migraine Medications May Cause 'Serotonin Syndrome'
Category: Health News
Created: 5/15/2008 2:00:00 AM
Last Editorial Review: 5/15/2008
Botox Works on Muscle Disorders But Not Migraines
Source: MedicineNet Dystonia Specialty [2008.05.06]
Title: Botox Works on Muscle Disorders But Not Migraines
Category: Health News
Created: 5/6/2008 2:00:00 AM
Last Editorial Review: 5/6/2008
Treximet Approved for Migraines
Source: MedicineNet sumatriptan Specialty [2008.04.21]
Title: Treximet Approved for Migraines
Category: Health News
Created: 4/19/2008 2:00:00 AM
Last Editorial Review: 4/21/2008
Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
Source: MedicineNet codeine Specialty [2008.04.18]
Title: Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
Category: Health News
Created: 4/18/2008 2:00:00 AM
Last Editorial Review: 4/18/2008
Epilepsy Drug Doesn't Prevent Migraines
Source: MedicineNet carbamazepine Specialty [2008.02.12]
Title: Epilepsy Drug Doesn't Prevent Migraines
Category: Health News
Created: 2/12/2008 2:00:00 AM
Last Editorial Review: 2/12/2008
New Combo Migraine Drug in the Works
Source: MedicineNet sumatriptan Specialty [2007.04.04]
Title: New Combo Migraine Drug in the Works
Category: Health News
Created: 4/4/2007
Last Editorial Review: 4/4/2007
Migraine
Source: MedicineNet Antiphospholipid Syndrome Specialty [2007.03.23]
Title: Migraine
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 3/23/2007
FDA Approvals: Adderall XR for Adults, Topamax for Migraines, and Others
Source: Medscape Primary Care Headlines [2004.08.19]
The FDA has approved an amphetamine-dextroamphetamine combination (Adderall XR) for use in adults, topiramate (Topamax) for migraine prophylaxis, a new dosing algorithm for radiation therapy (AAA), and two kinds of pentetate (Ca-DTPA and Zn-DTPA) for internal radiation contamination.
Medscape Medical News
Yael Waknine
NovaDel Announces Data From Pilot Efficacy Study Comparing Sumatriptan Oral Spray To Imitrex(R) Tablets
Source: Headache / Migraine News From Medical News Today [2008.09.06]
NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan (Sumatriptan OS) compared to sumatriptan tablets, marketed as Imitrex®/Imigran®, the leading triptan indicated for the treatment of migraine headaches.
|
